Skip to main content
. 2014 Feb 1;29(1):42–52. doi: 10.1089/cbr.2013.1526

FIG. 6.

FIG. 6.

Activity of caspase-3 and effect of z-VAD on cell viability of 4T1 cells. (A) Western blotting analysis of Caspase-3 cleavage. (B) MTT assay of cell viability in 4T1 cells 4 hours post SPDT treatment with or without Caspase inhibitor z-VAD pretreatment. *p<0.05 versus SPDT treatment.